End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30,150 KRW | +0.67% | -0.66% | -9.32% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The group's high margin levels account for strong profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Its low valuation, with P/E ratio at 7.12 and 6.26 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The company appears to be poorly valued given its net asset value.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The opinion of analysts covering the stock has improved over the past four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.32% | 330M | - | ||
+12.15% | 228B | B | ||
+14.90% | 196B | B- | ||
+18.22% | 141B | B- | ||
+29.15% | 110B | A- | ||
+0.53% | 65.88B | A- | ||
+16.92% | 54.3B | B+ | ||
+6.33% | 52.39B | B+ | ||
+10.93% | 45.22B | A | ||
+5.87% | 37.12B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- A043150 Stock
- Ratings Value Added Technology Co., Ltd.